Discovery of proangiogenic CD44+mesenchymal cancer stem cells in an acute myeloid leukemia patient’s bone marrow

Here, we report a unique acute myeloid leukemia (AML) bone marrow-derived mesenchymal stem cell (MSC) with both mesenchymal and endothelial potential, which we have named Mesenchymal Cancer Stem Cells (MCSCs). These MCSCs are CD90-CD13-CD44+ and differ from MSCs in isolation, expansion, differentiat...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Huynh, Xiao, Jeffrey, Reeves, Mark E., Payne, Kimberly, Chen, Chien Shing, Baylink, David J., Marcucci, Guido, Xu, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268388/
https://www.ncbi.nlm.nih.gov/pubmed/32493379
http://dx.doi.org/10.1186/s13045-020-00899-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268388/
https://www.ncbi.nlm.nih.gov/pubmed/32493379
http://dx.doi.org/10.1186/s13045-020-00899-x

Ejemplares similares